As of 2026-03-23, the Fair Value of Rocket Pharmaceuticals Inc (RCKT) is -10.28 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.34 USD, the upside of Rocket Pharmaceuticals Inc is -336.76%.
With the market price of 4.34 USD and our fair value calculation, Rocket Pharmaceuticals Inc (RCKT) is not a good investment. Investing in RCKT stocks now will result in a potential loss of 336.76%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -169.07 | -221.86 | -245.59 | -258.75 | -223.12 | -223.68 |
| YoY growth | -21.02% | -31.22% | -10.70% | -5.35% | 13.77% | -10.91% |
| Market Cap (mil) | 471.19 |
| P/E | |
| Forward P/E |
| EPS | -2.06 |
| Avg earnings growth rate | -10.91% |
| TTM earnings | -223.12 |